| DTIL Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the DTIL market cap history going back to 3/28/2019:
Also see: DTIL Shares Outstanding History and DTIL YTD Return |
As of 8/3/2026 Precision Biosciences has a market cap of 194.87 million. Investors often follow the DTIL market cap history to compare the size of the company over time.
This page shows DTIL market capitalization trends over time, with 30 market cap datapoints presented, dating back to 3/28/2019.

| DTIL Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the DTIL market cap history going back to 3/28/2019:
Also see: DTIL Shares Outstanding History and DTIL YTD Return |
| DTIL Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DTIL Historical Market Cap: -18.21% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DTIL Stock Price Chart |
| About Precision Biosciences Inc |
| Precision BioSciences, Inc. is an advanced gene editing company dedicated to improving life (DTIL) with its proprietary ARCUS genome editing platform. Using ARCUS, the Co.'s pipeline consists of in vivo gene editing candidates designed to deliver cures for a range of genetic and infectious diseases. The ARCUS platform develops in vivo gene editing therapies for gene edits, including gene elimination, insertion, and excision. ARCUS particularly generates defined outcomes due to predominant repair using homology directed repair (HDR) as opposed to non-homologous end joining (NHEJ). We show 30 historical shares outstanding datapoints in our DTIL shares outstanding history coverage, used to compute DTIL market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing DTIL market cap history over the course of time is important for investors interested in comparing DTIL's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of DTIL versus a peer is one thing; comparing DTIL market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like DTIL can fluctuate over the course of history. With this page we aim to empower investors researching DTIL by allowing them to research the DTIL market cap history. |
| DTIL Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| DTIL Share Performance |
| Market Cap Peers |
| Precision Biosciences (DTIL) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
DVA Market Cap History DVAX Market Cap History DVCR Market Cap History DWTX Market Cap History DXCM Market Cap History DYAI Market Cap History DYN Market Cap History DYNT Market Cap History EAR Market Cap History EBS Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.